skip navigation

Skip Nav

Clinical Guidelines Portal

Clinical Guidelines Portal

Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents

Appendix C: Panel Roster and Financial Disclosures


(Last updated: November 1, 2012; last reviewed: November 1, 2012)

Pneumocystis Pneumonia
 Member Financial Disclosure
 Company Relationship
Crothers, Kristina Yale University School of Medicine None N/A
 Furrer, Hansjakob  Universitatsspital Bern, Switzerland GlaxoSmithKline Advisory Board
 Helweg-Larsen, Jannik  Rigshospitalet, Copenhagen University, Denmark None N/A
Huang, Laurence University of California, San Francisco MiniVax Consultant
Kovacs, Joe*  National Institutes of Health None N/A
Miller, Robert

University College London, England

BMJ Publishing Group Honoraria
Gilead Honoraria, Speaker's Bureau
Mark Allen Healthcare Honoraria
Merck Honoraria, Speaker's Bureau
NIH Research Support
Morris, Alison 
University of Pittsburgh Medical School

Associates of Cape Cod Research Support
Gilead Research Support
NIH Research Support
Roche Research Support
*Group Lead
Note: Members were asked to disclose all relationships from 24 months before the writing panel convened. The period of reporting was from June 1, 2008, through November 1, 2012.

Back to Top